NVO technical analysis
NVO Technical Analysis
Analysis date
July 15, 2026
Market
NYSE (USD)
Daily cutoff
July 14, 2026
Reliability
Passed
Informational use only. This page is not investment advice.
Data verification
NVO Data Verification
Cross-validating the latest completed daily bar across independent sources.
- Symbol
- NVO
- Market
- NYSE
- Currency
- USD (US Dollar)
- Latest completed bar
- July 14, 2026
No adjustment factor (adjusted close equals raw close, factor 1.0). No stock splits or dividend adjustments affecting the analysis period.
| Source | Latest Close | Date | Difference | Status |
|---|---|---|---|---|
| Yahoo Finance Chart API (primary) | 105.12 | July 14, 2026 | - | Verified |
| Finviz (independent) | 105.12 | July 14, 2026 (previous close) | 0.00% | Verified |
Bottom line
NVO Technical Analysis Summary
NVO (Novo Nordisk) shows a mixed technical picture after a significant correction from its all-time highs. On the daily chart, price at 105.12 has fallen below SMA20 (108.45, -3.07%) and SMA50 (111.30, -5.55%), indicating short-term bearish momentum. The stock is still above SMA200 (98.76, +6.44%), confirming the longer-term uptrend remains intact. RSI14 at 42.15 on the daily chart reflects bearish momentum without oversold conditions. The daily MACD has generated a bearish crossover with the MACD line crossing below the signal line, and the histogram at -1.83 is negative. The weekly timeframe shows price holding above SMA20 (103.40) and SMA200 (86.27), though RSI at 48.72 has dipped below the 50 midline. Key support lies at SMA200 (98.76) and the 60-day low (96.50). Resistance rests at 108.45 (SMA20) and 111.30 (SMA50). The GLP-1 sector remains structurally strong, but the stock is in a corrective phase after the post-Ozempic run-up.
Multi-timeframe dashboard
Multi-Timeframe Technical Dashboard
Comparing daily (2-year) and weekly (5-year) perspectives to identify aligned or conflicting signals.
Daily (July 14, 2026)
- Trend
- Bearish in the short term. Price at 105.12 is below SMA20 (108.45, -3.07%) and SMA50 (111.30, -5.55%) but remains above SMA200 (98.76, +6.44%). SMA20 and SMA50 are sloping downward while SMA200 continues to rise, creating a bearish short-term but bullish long-term divergence. The stock has given back gains from the May-June rally.
- Momentum
- Bearish with weakening bias. RSI14 at 42.15 is below the 50 midline, indicating bearish momentum without being oversold. MACD line at -1.24 has crossed below the signal line at 0.59, and the histogram at -1.83 is negative — a bearish crossover signal that suggests momentum is shifting against the bulls.
- Volatility
- Moderate. ATR14 at 2.47 (2.35% of price) suggests average daily movement of about 2.4%. Bollinger Bands (97.82 to 112.64) show price in the lower half of the range. Band width is moderate, indicating normal volatility conditions for a large-cap pharma stock.
- Volume
- Near average. Latest volume of 4,823,500 is 92.1% of the 20-period average (5,236,400), indicating typical participation levels. No unusual selling pressure detected.
Assessment
The daily chart shows NVO in a short-term corrective phase. Price breaking below both SMA20 and SMA50 is a bearish signal, and the MACD bearish crossover confirms negative short-term momentum. RSI at 42.15 leaves room for further downside before reaching oversold territory. However, the stock remains well above SMA200 (98.76), and the 52-week position at 62.4% suggests the correction has room to extend before reaching structurally important support. A test of SMA200 around 98-99 would be a natural next level to watch. Volume has been relatively normal during the decline, suggesting orderly selling rather than panic distribution.
Weekly (July 6, 2026 week)
- Trend
- Neutral with underlying bullish structure. Price at 103.87 is above SMA20 (103.40) and well above SMA200 (86.27) but has dipped below SMA50 (106.35). SMA20 is flattening while SMA50 is starting to turn down, but SMA200 continues to slope upward. The stock remains in a structural uptrend from the 2023-2025 GLP-1 bull run.
- Momentum
- Neutral with bearish tilt. RSI14 at 48.72 has dipped below the 50 midline, a shift from the consistently bullish readings seen through 2024 and early 2025. MACD line at 0.31 has crossed below the signal line at 1.45, and the histogram at -1.14 is negative, indicating deteriorating weekly momentum.
- Volatility
- Moderate. ATR14 at 4.75 (4.57% of price) reflects typical weekly ranges for a large-cap pharma stock. Bollinger Bands (94.06 to 119.28) show price below the middle band, consistent with the corrective phase.
- Volume
- Slightly above average. Weekly volume of 23,841,000 is 104.8% of the 20-week average (22,749,000), indicating marginally elevated participation during the correction.
Assessment
The weekly chart presents a nuanced picture. While short-term momentum has clearly deteriorated, the structural uptrend remains intact, with SMA200 at 86.27 providing a long-term support reference. The weekly RSI at 48.72 is neutral - neither confirming a trend reversal nor signaling a buying opportunity. The stock is in what appears to be a healthy correction within a longer-term uptrend. A weekly close below SMA20 (103.40) would be the first warning, followed by the 60-week low at 95.38. The GLP-1 market outlook remains strong, and the fundamental thesis for Novo Nordisk has not changed.
Key indicators
NVO Key Technical Indicators
RSI, MACD, moving averages, ATR, and Bollinger Bands across daily and weekly timeframes.
| Indicator | Daily | Weekly |
|---|---|---|
| RSI (14) | 42.15 | 48.72 |
| MACD (12, 26, 9) | -1.24 / 0.59 / -1.83 | 0.31 / 1.45 / -1.14 |
| ATR (14) | 2.47 (2.35%) | 4.75 (4.57%) |
| Bollinger Bands (20, 2) | 97.82 - 112.64 | 94.06 - 119.28 |
| SMA (20) | 108.45 | 103.40 |
| SMA (50) | 111.30 | 106.35 |
| SMA (200) | 98.76 | 86.27 |
Price structure
NVO Price Structure and Returns
Price performance across multiple lookback periods and 52-week position.
| Metric | Daily | Weekly |
|---|---|---|
| Current Price | 105.12 | 103.87 |
| 1-Period Return | -1.15% | -2.34% |
| 5-Period Return | -3.72% | -5.18% |
| 20-Period Return | -4.28% | -2.95% |
| 60-Period Return | -8.51% | +3.16% |
| 252-Period Return | +12.45% | +19.83% |
| 52-Week Low | 72.14 | 72.14 |
| 52-Week High | 125.04 | 125.04 |
| 52-Week Position | 62.40% | 59.70% |
Key levels
NVO Support and Resistance Levels
Key price levels based on recent swing highs and lows across daily and weekly timeframes.
| Level | Daily | Weekly |
|---|---|---|
| 20-Period High | 115.28 | 119.28 |
| 20-Period Low | 96.50 | 95.38 |
| 60-Period High | 125.04 | 125.04 |
| 60-Period Low | 96.50 | 89.12 |
Scenarios
NVO Technical Scenarios
Conditions, invalidation triggers, and what to watch for each scenario.
Bullish
Trigger
Price reclaims SMA20 (108.45) on the daily chart with above-average volume, followed by a break above SMA50 (111.30).
Invalidation
Price falls below SMA200 (98.76) and breaks the 20-day low at 96.50.
What to watch
Daily RSI climbing back above 50; MACD histogram turning less negative; weekly RSI holding above 45; volume increasing on up days.
Range-Bound
Trigger
Price oscillates between SMA200 support (98.76) and SMA20 resistance (108.45) as the correction plays out without a clear directional catalyst.
Invalidation
A decisive break above 108.45 or below 96.50 with increasing volume.
What to watch
RSI staying between 35 and 50; MACD histogram fluctuating near zero; volume returning to average or below; news flow around GLP-1 pipeline updates.
Bearish
Trigger
Price breaks below SMA200 (98.76) and the 60-day low at 96.50, suggesting the correction is deepening into a structural trend change.
Invalidation
Price reclaims SMA50 (111.30) and establishes support above 105.
What to watch
Daily RSI falling toward 30; MACD histogram becoming more negative; volume increasing on down days; weekly MACD diverging further below the signal line; competitive developments in the GLP-1 market.
Methodology
Methodology and Limitations
This technical analysis uses adjusted closing prices from Yahoo Finance (primary) and Finviz (independent cross-validation). The daily analysis covers approximately 2 years (501 completed bars) ending July 14, 2026. The weekly analysis covers approximately 5 years (261 completed bars) ending the week of July 6, 2026. Prices are adjusted for dividends and stock splits using the adjusted close/raw close ratio. Volume data is from the primary source and may not match other data providers. Technical indicators include SMA, RSI, MACD, ATR, and Bollinger Bands using standard parameters. Key levels are identified from recent swing highs and lows. Technical analysis studies historical price patterns and does not constitute investment advice. It should not be used as the sole basis for trading decisions.
Frequently Asked Questions
This technical analysis is for informational and educational purposes only. It does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Past performance and historical patterns are not guarantees of future results. All investments carry risk, including the potential loss of principal. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data sourced from Yahoo Finance (primary) and Finviz (independent cross-validation). Data cutoffs: daily July 14, 2026, weekly July 6, 2026 week. Generated July 15, 2026.
Related Tools
AI Chart Analyzer
Upload a TradingView chart screenshot and get instant AI-powered technical analysis. Identify patterns, support and resistance, and key levels.
Support and Resistance Calculator
Calculate key support and resistance levels for any stock. Identify potential price zones where reversals or breakouts may occur.
RSI Calculator
Calculate the Relative Strength Index for any stock. Determine overbought and oversold conditions with customizable periods.